Showing results (661-670 of 1,163) with videos related to
Sort By:
Pageof 117
European Journal of Heart Failure|January 21, 2022
Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fractionChanchal Chandramouli, Tay W Ting, Jasper Tromp, et al.JAMA Cardiology|November 13, 2020
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA TrialCarolyn S P Lam, Anna Giczewska, Karen Sliwa, et al.Journal of Cardiac Failure|June 18, 2023
Classification of Heart Failure Events by Severity: Insights From the VICTORIA TrialG Michael Felker, Rebecca North, Hillary Mulder, et al.Journal of the American College of Cardiology|March 21, 2020
Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/ValsartanSenthil Selvaraj, Brian L Claggett, Michael Böhm, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 23, 2023
Fully Automated Artificial Intelligence Assessment of Aortic Stenosis by EchocardiographyHema Krishna, Kevin Desai, Brody Slostad, et al.JAMA|November 9, 2015
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized TrialMihai Gheorghiade, Stephen J Greene, Javed Butler, et al.Cardiovascular Research|September 2, 2020
The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fractionCoenraad Withaar, Laura M G Meems, George Markousis-Mavrogenis, et al.Diabetes & Metabolism|June 26, 2022
Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitorsMei-Zhen Wu, Chanchal Chandramouli, Pui-Fai Wong, et al.JACC. Heart Failure|October 17, 2017
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA TrialPaul W Armstrong, Lothar Roessig, Mahesh J Patel, et al.JACC. Heart Failure|June 27, 2024
Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status: Insights From the VICTORIA TrialMuhammad Shahzeb Khan, Javed Butler, Rebecca Young, et al.Pageof 117